Ney Carter Borges on Colchicine As 2ry Prevention in Atherosclerotic CVD
Ney Carter Borges, Member Cardiologist of Global Physician Association at Cleveland Clinic Florida, shared on LinkedIn:
”Low-dose colchicine (0.5 mg/day) has emerged as an effective anti-inflammatory strategy for secondary prevention in atherosclerotic cardiovascular disease.
By inhibiting microtubule assembly, colchicine suppresses activation of the NLRP3 inflammasome, leading to reduced interleukin-1β and interleukin-6 signaling, key drivers of plaque inflammation and instability.
Clinical trial data demonstrate that colchicine significantly stabilizes atherosclerotic plaques, attenuates neutrophil activation, and reduces thrombogenic potential.
A pooled analysis of randomized trials shows a 25% relative reduction in major adverse cardiovascular events (HR ~0.75), with consistent reductions in myocardial infarction (≈23%), ischemic stroke (≈22%), and cardiovascular mortality (≈34%).
These benefits occur without an increase in non-cardiovascular mortality and with good tolerability in most patients.
Taken together, these findings position colchicine as a third pillar of secondary prevention, complementing lipid-lowering and antithrombotic therapies by targeting residual inflammatory risk in patients with established atherosclerosis.”
Stay updated with Hemostasis Today.
-
Apr 25, 2026, 11:44Ruiming Li: Why the COMBO Plus form is a Masterclass in Vascular Repair
-
Apr 25, 2026, 11:19Nathan Connell: Bleeding Risk Is Not Limited to Delivery
-
Apr 25, 2026, 11:14Rashad Mohamed: What Does ‘Capping’ Mean in Anticoagulant Dosing?
-
Apr 25, 2026, 11:07Anne de Vaan: The Results of the PRIDES Study Are Now Available
-
Apr 25, 2026, 10:50Flora Peyvandi: Proteomic Insights of Relapse Risk in Thrombotic Thrombocytopenic Purpura
-
Apr 25, 2026, 10:40Kalyan Roy: Effect of Irradiation on Red Blood Cells
-
Apr 25, 2026, 10:38David Sinclair: How are High Omega-3 Levels Linked to Low Mortality Risk
-
Apr 25, 2026, 10:26Melissa Hollo: How HerCare Utilizes Hierarchical Algorithm of Severe Maternal Morbidity
-
Apr 25, 2026, 10:05Lutz Knabe: One Child’s Journey from Pain to Hope Beyond Severe Bleeding Disorder